Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision

Core Viewpoint - Tevogen Bio emphasizes its commitment to preserving equity for shareholders while exploring financing strategies in the biotech sector, focusing on efficiency, asset ownership, and a path to revenue [1][2]. Company Overview - Tevogen Bio is a clinical-stage specialty immunotherapy company that develops off-the-shelf, genetically unmodified precision T cell therapies targeting infectious diseases and cancers, addressing significant unmet needs in large patient populations [2]. - The company has reported positive safety data from its proof-of-concept clinical trial and owns key intellectual property assets, including three granted patents and multiple pending patents, with two related to artificial intelligence [2]. Leadership and Strategy - Tevogen Bio is led by a team of experienced industry leaders and scientists with expertise in drug development and global product launches, believing that accessible personalized therapeutics represent the next frontier of medicine [3]. - The company advocates for disruptive business models to sustain medical innovation and ensure patient accessibility through advanced science [3]. Financial Position - Tevogen Bio's assets are valued in the billions, although this value is not reflected on its balance sheet due to US GAAP restrictions on capitalizing internally developed intangible assets [5]. - The company's market cap per employee is approximately 600% higher than the industry average, indicating strong operational efficiency [5]. - Tevogen has a self-sustaining financing strategy, with multiple avenues to secure funds without selling equity, aiming for long-term sustainability [5]. Business Model - Tevogen's business model challenges traditional biotech financing norms, focusing on making advanced immunotherapies accessible and affordable [5]. - The company believes that its true value will become more recognized as awareness grows, and encourages employee ownership as a means to align interests [5].